首页 | 本学科首页   官方微博 | 高级检索  
     

原位RRM1和ERCC1蛋白表达水平预测吉西他滨为基础化疗方案对非小细胞肺癌的疗效
引用本文:周彩存,徐崇锐. 原位RRM1和ERCC1蛋白表达水平预测吉西他滨为基础化疗方案对非小细胞肺癌的疗效[J]. 循证医学, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
作者姓名:周彩存  徐崇锐
作者单位:1.上海市肺科医院肿瘤科,上海 200433;; 2.广东省人民医院肿瘤中心、广东省肺癌研究所、广东省医学科学院,广州 510080
摘    要:1 文献来源 Reynolds C, Obasaju C, Schell M J, et al. Randomized phase IU trial of Gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer[J]. J Clin Oncol, 2009,27(34):5808-5815.

关 键 词:肺肿瘤  ERCC1  RRM1  吉西他滨

Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer
ZHOU Cai-chun,XU Chong-rui. Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer[J]. The Journal of Evidence-Based Medicine, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
Authors:ZHOU Cai-chun  XU Chong-rui
Affiliation:Reviewers’ address:Oncology Department, Shanghai Pulmonary Hospital, Shanghai 200433, China
Abstract:lung neoplasms ERCC1 RRM1 Gemcitabine
Keywords:ERCC1  RRM1  lung neoplasms  ERCC1  RRM1  Gemeitabine
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《循证医学》浏览原始摘要信息
点击此处可从《循证医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号